Filtered By:
Drug: Aspirin
This page shows you your search results in order of relevance. This is page number 15.
Order by Relevance | Date
Total 5429 results found since Jan 2013.
A Review of Aspirin-exacerbated Respiratory Diseases and Immunological Efficacy of Aspirin Desensitization
Iran J Allergy Asthma Immunol. 2022 Oct 26;21(5):512-523. doi: 10.18502/ijaai.v21i5.11039.ABSTRACTAspirin-exacerbated respiratory disease (AERD) is a chronic inflammatory disease. It is defined by asthma, chronic rhinosinusitis with nasal polyposis, and a hypersensitivity reaction to aspirin or nonsteroidal anti-inflammatory drugs. Aspirin desensitization (AD) has been confirmed as an effective treatment to control AERD inflammation through the modulation of immune responses. We aimed to review AERD with an overview of the epidemiology, pathophysiology, and treatment. We also discussed the effect of AD on immunological ma...
Source: Iranian Journal of Allergy, Asthma and Immunology - November 7, 2022 Category: Allergy & Immunology Authors: Hossein Esmaeilzadeh Maryam Zare Soheila Alyasin Hesamedin Nabavizadeh Negar Mortazavi Zahra Kanannejad Source Type: research
Prior Statin Use and The Incidence of Arrhythmia in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
CONCLUSIONS: Based on aggregate patient data, prior statin use may reduce the incidence of in-hospital arrhythmia during ACS, particularly atrial fibrillation or atrial flutter and ventricular tachycardia or ventricular fibrillation.PMID:36642406 | DOI:10.1016/j.ihj.2023.01.004
Source: Indian Heart J - January 15, 2023 Category: Cardiology Authors: Kevin Wibawa Raditya Dewangga Kintan Sari Nastiti Pangeran Akbar Syah Suhendiwijaya Suhendiwijaya Yandi Ariffudin Source Type: research
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction
CONCLUSION: Aspirin, L-arginine and vitamin D are promising, high potential preventative agents for fetal growth restriction. Based on the medicines pipeline, new pharmacological agents for fetal growth restriction are unlikely to emerge in the near future.PMID:36655375 | DOI:10.1111/1471-0528.17392
Source: BJOG : An International Journal of Obstetrics and Gynaecology - January 19, 2023 Category: OBGYN Authors: Shao Lim Annie R A McDougall Maya Goldstein Andrew Tuttle Roxanne Hastie Stephen Tong Anne Ammerdorffer Sara Rushwan Christina Ricci A Metin Gulmezoglu Joshua P Vogel Source Type: research
Prior Statin Use and The Incidence of Arrhythmia in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis
CONCLUSIONS: Based on aggregate patient data, prior statin use may reduce the incidence of in-hospital arrhythmia during ACS, particularly atrial fibrillation or atrial flutter and ventricular tachycardia or ventricular fibrillation.PMID:36642406 | DOI:10.1016/j.ihj.2023.01.004
Source: Indian Heart J - January 15, 2023 Category: Cardiology Authors: Kevin Wibawa Raditya Dewangga Kintan Sari Nastiti Pangeran Akbar Syah Suhendiwijaya Suhendiwijaya Yandi Ariffudin Source Type: research
Analysis of a maternal health medicines pipeline database 2000-2021: New candidates for the prevention and treatment of fetal growth restriction
CONCLUSION: Aspirin, L-arginine and vitamin D are promising, high potential preventative agents for fetal growth restriction. Based on the medicines pipeline, new pharmacological agents for fetal growth restriction are unlikely to emerge in the near future.PMID:36655375 | DOI:10.1111/1471-0528.17392
Source: BJOG : An International Journal of Obstetrics and Gynaecology - January 19, 2023 Category: OBGYN Authors: Shao Lim Annie R A McDougall Maya Goldstein Andrew Tuttle Roxanne Hastie Stephen Tong Anne Ammerdorffer Sara Rushwan Christina Ricci A Metin Gulmezoglu Joshua P Vogel Source Type: research
Prior statin use and the incidence of in-hospital arrhythmia in acute coronary syndrome: A systematic review and meta-analysis
CONCLUSIONS: Based on aggregate patient data, prior statin use may reduce the incidence of in-hospital arrhythmia during ACS, particularly atrial fibrillation or atrial flutter and ventricular tachycardia or ventricular fibrillation.PMID:36642406 | DOI:10.1016/j.ihj.2023.01.004
Source: Indian Heart J - January 15, 2023 Category: Cardiology Authors: Kevin Wibawa Raditya Dewangga Kintan Sari Nastiti Pangeran Akbar Syah Suhendiwijaya Suhendiwijaya Yandi Ariffudin Source Type: research
